The central melanocortin system and energy homeostasis

Trends in Endocrinology and Metabolism

Volumn 10, Issue 6, 1999, Pages 211-216

  Cone, Roger D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; LEPTIN; MELANOCORTIN; MESSENGER RNA; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; MELANOCORTIN RECEPTOR;

BODY MASS; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; MELANOCYTE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; ALLELE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DOMINANT INHERITANCE; ENERGY BALANCE; GENE MUTATION; GENETIC PREDISPOSITION; HETEROZYGOSITY; PHENOTYPE; RISK FACTOR;

EID: 0032772960     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(99)00153-8     Document Type: Review

References (53)

1. Zhang Y.et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
2. Tartaglia L.A.et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1995;1263-1271.
3. Bultman S.J., Michaud E.J., Woychik R.P. Molecular characterization of the mouse agouti locus. Cell. 71:1992;1195-1204.
4. Lu D.et al. Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature. 371:1994;799-802.
5. Fan W.et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
6. Huszar D.et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
7. Satoh N.et al. The arcuate nucleus as a primary site of satiety effects of leptin in rats. Neurosci. Lett. 224:1997.
8. Montague C.T.et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:1997;903-908.
9. Ahima R.et al. Role of leptin in the neuroendocrine response to fasting. Nature. 382:1996;250-252.
10. vy/a) mice. J. Hered. 77:1986;151-158.
11. Lu D., Chen W., Cone R. Regulation of melanogenesis by the MSH receptor. Nordlund J.et al. The Pigmentary System. 1998;183-197 Oxford University Press.
12. Frigeri L.G., Wolff G.L., Robel G. Impairment of glucose tolerance in yellow (Avy/A) (Balb/c × VY) F-1 hybrid mice by hyperglycemic peptide(s) from human pituitary glands. Endocrinology. 113:1983;2097-2105.
13. Wolff G.L., Flack J.D. Genetic regulation of plasma corticosterone concentration and its response to castration and allogeneic tumor growth in the mouse. Nature. 232:1971;181-182.
14. Wolff G.L. Growth of inbred yellow (Ay) and non-yellow (aa) mice in parabiosis. Genetics. 48:1963;1041-1058.
15. Manne J., Argeson A.C., Siracusa L.D. Mechanisms for the pleiotropic effects of the agouti gene. Proc. Natl. Acad. Sci. U. S. A. 92:1995;4721-4724.
16. Silvers W.K., Russel E.S. An experimental approach to action of genes at the agouti locus in the mouse. J. Exp. Zool. 130:1955;199-220.
17. Gantz I.et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268:1993;15174-15179.
18. Mountjoy K.G.et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8:1994;1298-1308.
19. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38:1995;3454-3461.
20. Frigeri L.G., Wolff G.L., Teguh C. Differential responses of yellow Avy/A and agouti A/a (Balb/c × VY) F-1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity. Int. J. Obes. 12:1988;305-320.
21. Shutter J.R.et al. Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Genes Dev. 11:1997;593-602.
22. Ollmann M.M.et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:1997;135-137.
23. Haskell-Luevano C.et al. Characterization of the neuroanatomical distribution of agouti-related protein (AGRP) immunoreactivity in the rhesus monkey and the rat. Endocrinology. 140:1999;1408-1415.
24. Chen P.et al. Coexpression of agouti related transcript (ART) and neuropeptide Y (NPY) in the hypothalamic arcuate nucleus of female rats during the estrous cycle and lactation. Endocrinology. 140:1999;2645-2650.
25. Mizuno T.M., Mobbs C.V. Hypothalamic agouti-related messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology. 140:1999;814-817.
26. Fong T.M.et al. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem. Biophys. Res. Commun. 237:1997;629-631.
27. Graham M.et al. Overexpression of Agrt leads to obesity in transgenic mice. Nat. Genet. 17:1997;273-274.
28. Brady L.S., Smith M.A., Gold P.W., Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology. 52:1990;441-447.
29. Thornton J.E., Cheung C.C., Clifton D.K., Steiner R.A. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology. 138:1997;5063-5066.
30. Schwartz M.W.et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 46:1997;2119-2123.
31. Beaulieu S., Gagne B., Barden N. Glucocorticoid regulation of proopiomelanocortin messenger ribonucleic acid content of rat hypothalamus. Mol. Endocrinol. 2:1988;727-731.
32. Smith M.S. Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. Endocrinology. 133:1993;1258-1265.
33. Erickson J., Hollopeter G., Palmiter J.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274:1996;1704-1707.
34. Gura T. Obesity sheds its secrets. Science. 275:1997;751-753.
35. Friedman J.M. The alphabet of weight control. Nature. 385:1997;119-120.
36. Cheung C.C., Clifton D.K., Steiner R.A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology. 138:1997;4489-4492.
37. Halaas J.L.et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. U. S. A. 94:1997;8878-8883.
38. Kesterson R.A.et al. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol. Endocrinol. 11:1997;630-637.
39. Boston B.A., Blaydon K.M., Varnerin J., Cone R.D. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science. 278:1997;1641-1644.
40. Seeley R.J.et al. Melanocortin receptors in leptin effects. Nature. 390:1997;349.
41. Uehara Y.et al. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes. 47:1998;890-893.
42. Goldstone A.P.et al. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett. 415:1997;134-138.
43. Smith A.I., Funder J.W. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr. Rev. 9:1988;159-179.
44. Woods S.C., Seeley R.J., Porte D. Jr., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science. 280:1998;1378-1382.
45. Stanley B.G.et al. The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res. 604:1993;304-317.
46. Ahlshog J.E., Hoebel B.G. Overeating and obesity from damage to a noradrenergic system in the rat brain. Science. 182:1973;166-169.
47. Jin S.L.et al. Distribution of glucagon-like peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J. Comp. Neurol. 271:1988;519-532.
48. Heinrichs S.C.et al. Corticotropin-releasing factor in paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 611:1993;18-24.
49. Krude H.et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19:1998;155-157.
50. Comuzzie A.G.et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat. Genet. 15:1997;273-276.
51. Yeo G.S.H.et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20:1998;111-112.
52. Vaisse C., Clement K., Guy-Grand B., Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20:1998;113-114.
53. Marsh D.J.et al. Response of melanocortin-4 receptor deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21:1999;119-122.